These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6763142)

  • 21. Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients.
    Hökfelt B; Hedeland H; Dymling JF
    Eur J Pharmacol; 1970; 10(3):389-97. PubMed ID: 5422465
    [No Abstract]   [Full Text] [Related]  

  • 22. [Increased activity of the sympathetic nervous system and the possibilities for therapeutic influence].
    Soucek M; Nevrlka J; Rihácek I; Frána P; Plachý M
    Vnitr Lek; 2007 May; 53(5):554-9. PubMed ID: 17642445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rebuttal from Esler, Lambert, and Schlaich.
    Esler M; Lambert E; Schlaich M
    J Appl Physiol (1985); 2010 Dec; 109(6):2000-1. PubMed ID: 21148350
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pathophysiology of hypertension].
    Lydtin H
    Z Allgemeinmed; 1975 Nov; 51(33):1511-8. PubMed ID: 1108461
    [No Abstract]   [Full Text] [Related]  

  • 25. An apraisal of the role of aldosterone and the sympathetic nervous system in essential hypertension.
    Rosenthal J
    Horm Metab Res; 1979 Jun; 11(6):379-82. PubMed ID: 381138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the sympathetic nervous system in human hypertension.
    Grassi G
    J Hypertens; 1998 Dec; 16(12 Pt 2):1979-87. PubMed ID: 9886886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurogenic factors in hypertension: therapeutic implications.
    Campese VM
    Ann Ital Med Int; 1994 Oct; 9 Suppl():39S-43S. PubMed ID: 7857755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinapril ACE-inhibition effects on adrenergic parameters in moderate essential hypertension.
    Vallès Prats M; Matas Serra M; Bronsoms Artero J; Matè Benito G; Torguet Escuder P; Mauri Nicolas JM
    Kidney Int Suppl; 1996 Jun; 55():S104-6. PubMed ID: 8743525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of sympathetic nervous function in low-renin essential hypertension.
    Esler M; Randall O; Bennett J; Zweifler A; Julius S; Rydelek P
    Lancet; 1976 Jul; 2(7977):115-8. PubMed ID: 59183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sympathetic activity, blood pressure variability and end organ damage in hypertension.
    Mancia G; Di Rienzo M; Parati G; Grassi G
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S3-8. PubMed ID: 9321734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mild chronic renal insufficiency induces sympathetic overactivity.
    Tinucci T; Abrahão SB; Santello JL; Mion D
    J Hum Hypertens; 2001 Jun; 15(6):401-6. PubMed ID: 11439315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of ramipril on sympathetic nervous system function in older patients with hypertension.
    Lee CC; Sidani MA; Hogikyan RV; Supiano MA
    Clin Pharmacol Ther; 1999 Apr; 65(4):420-7. PubMed ID: 10223780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term drug therapy of arterial hypertension including patient compliance].
    Linss G; Kiesewetter R
    Z Arztl Fortbild (Jena); 1984; 78(24):1047-53. PubMed ID: 6442069
    [No Abstract]   [Full Text] [Related]  

  • 35. Salt supresses baseline muscle sympathetic nerve activity in salt-sensitive and salt-resistant hypertensives.
    Abrahão SB; Tinucci T; Santello JL; Mion D
    J Hum Hypertens; 2002 Dec; 16(12):843-50. PubMed ID: 12522465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated sympathetic nerve activity in patients with accelerated essential hypertension.
    Matsukawa T; Mano T; Gotoh E; Ishii M
    J Clin Invest; 1993 Jul; 92(1):25-8. PubMed ID: 8325991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
    Chikhladze NM
    Ter Arkh; 2000; 72(12):67-9. PubMed ID: 11201840
    [No Abstract]   [Full Text] [Related]  

  • 38. [Some aspects of the physiopathology of arterial hypertension].
    Francischetti EA; Oigman W; Fagundes VG; Netto FR; Sanjuliani AF; Brandão AP
    Arq Bras Cardiol; 1984 Feb; 42(2):153-65. PubMed ID: 6089717
    [No Abstract]   [Full Text] [Related]  

  • 39. Sympathetic nervous system and blood-pressure control in essential hypertension.
    Philipp T; Distler A; Cordes U
    Lancet; 1978 Nov; 2(8097):959-63. PubMed ID: 81987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of catecholamines in hypertensive mechanisms of essential hypertension].
    Iimura O; Kikuchi K; Yamaji I; Suzuki S; Shimazaki M; Kudo C; Mukai H
    Nihon Rinsho; 1989 Sep; 47(9):1947-55. PubMed ID: 2593268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.